- Home
- JAKK vs MREO Comparison
JAKK vs MREO Comparison
Compare JAKK & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- MREO
- Stock Information
- Founded
- JAKK 1995
- MREO 2015
- Country
- JAKK United States
- MREO United Kingdom
- Employees
- JAKK N/A
- MREO N/A
- Industry
- JAKK Recreational Games/Products/Toys
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- JAKK Consumer Discretionary
- MREO Health Care
- Exchange
- JAKK Nasdaq
- MREO Nasdaq
- Market Cap
- JAKK 374.4M
- MREO 369.2M
- IPO Year
- JAKK 1996
- MREO N/A
- Fundamental
- Price
- JAKK $24.63
- MREO $2.26
- Analyst Decision
- JAKK Strong Buy
- MREO Strong Buy
- Analyst Count
- JAKK 5
- MREO 7
- Target Price
- JAKK $41.00
- MREO $7.71
- AVG Volume (30 Days)
- JAKK 129.1K
- MREO 1.2M
- Earning Date
- JAKK 04-23-2025
- MREO 03-26-2025
- Dividend Yield
- JAKK 1.02%
- MREO N/A
- EPS Growth
- JAKK N/A
- MREO N/A
- EPS
- JAKK 3.14
- MREO N/A
- Revenue
- JAKK $691,042,000.00
- MREO N/A
- Revenue This Year
- JAKK $2.34
- MREO N/A
- Revenue Next Year
- JAKK $4.14
- MREO $69.09
- P/E Ratio
- JAKK $7.84
- MREO N/A
- Revenue Growth
- JAKK N/A
- MREO N/A
- 52 Week Low
- JAKK $17.06
- MREO $2.16
- 52 Week High
- JAKK $35.79
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- JAKK 37.89
- MREO 33.19
- Support Level
- JAKK $24.54
- MREO $2.23
- Resistance Level
- JAKK $26.49
- MREO $2.73
- Average True Range (ATR)
- JAKK 0.87
- MREO 0.14
- MACD
- JAKK 0.13
- MREO -0.01
- Stochastic Oscillator
- JAKK 23.94
- MREO 7.89
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-brand toy company that designs, produces, markets, and distributes toys and related products, consumables, and related products, electronics and related products, kids' indoor and outdoor furniture, and other consumer products. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).